QS Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $371K | Hold |
3,884
| – | – | ﹤0.01% | 856 |
|
|
2021
Q1 | $443K | Buy |
3,884
+50
| +1% | +$5.7K | 0.01% | 841 |
|
|
2020
Q4 | $531K | Sell |
3,834
-66
| -2% | -$9.14K | 0.01% | 760 |
|
|
2020
Q3 | $321K | Sell |
3,900
-12,200
| -76% | -$1M | ﹤0.01% | 895 |
|
|
2020
Q2 | $1.26M | Hold |
16,100
| – | – | 0.02% | 655 |
|
|
2020
Q1 | $716K | Hold |
16,100
| – | – | 0.01% | 754 |
|
|
2019
Q4 | $695K | Hold |
16,100
| – | – | 0.01% | 848 |
|
|
2019
Q3 | $689K | Hold |
16,100
| – | – | 0.01% | 867 |
|
|
2019
Q2 | $1.02M | Buy |
16,100
+15,200
| +1,689% | +$966K | 0.01% | 788 |
|
|
2019
Q1 | $63K | Sell |
900
-7
| -0.8% | -$490 | ﹤0.01% | 1477 |
|
|
2018
Q4 | $40K | Hold |
907
| – | – | ﹤0.01% | 1469 |
|
|
2018
Q3 | $69K | Hold |
907
| – | – | ﹤0.01% | 1456 |
|
|
2018
Q2 | $70K | Hold |
907
| – | – | ﹤0.01% | 1474 |
|
|
2018
Q1 | $46K | Hold |
907
| – | – | ﹤0.01% | 1487 |
|
|
2017
Q4 | $42K | Hold |
907
| – | – | ﹤0.01% | 1506 |
|
|
2017
Q3 | $48K | Hold |
907
| – | – | ﹤0.01% | 1532 |
|
|
2017
Q2 | $56K | Hold |
907
| – | – | ﹤0.01% | 1486 |
|
|
2017
Q1 | $61K | Buy |
907
+900
| +12,857% | +$60.5K | ﹤0.01% | 1464 |
|
|
2016
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 1709 |
|
|
2016
Q3 | $1K | Buy |
7
+2
| +40% | +$286 | ﹤0.01% | 1698 |
|
|
2016
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1745 |
|
|
2016
Q1 | – | Sell |
-3
| Closed | -$1K | – | 2047 |
|
|
2015
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1769 |
|